Trials / Completed
CompletedNCT05128435
Coronavirus Pediatric Serological Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Centre Hospitalier Universitaire Saint Pierre · Academic / Other
- Sex
- All
- Age
- 0 Months – 179 Months
- Healthy volunteers
- Accepted
Summary
The Coronavirus Pediatric Serological Study's aim is to provide a better insight of children's immune response after SARS-CoV-2 infection. Serological tests were conducted on blood samples taken 3 to 5 months after the children's viral infection. The study was performed in collaboration with the Institute of Medical Immunology, were antibody levels were measured and immunoglobulin subclasses profiles were studied.
Detailed description
The hospital laboratory provided us the list of children under 15 years old tested for SARS-CoV-2 in Saint-Pierre Hospital (Brussels) by PCR on nasopharyngeal swab between March 1 2020 and December 31 2020. The medical files of all children that were tested positive for SARS-CoV-2 were reviewed and clinical information was collected. For each positive child, the family was contacted by phone 3 months after the proven viral infection in order to ask permission to take a single blood test. Covid19 serologies were performed in the hospital laboratory, and blood samples were then sent to the Institute of Medical Immunology, were antibody levels and immunoglobulin subclasses were studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sample | Blood sample taken 3 to 5 months after the infection |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-12-31
- Completion
- 2021-05-31
- First posted
- 2021-11-22
- Last updated
- 2021-11-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05128435. Inclusion in this directory is not an endorsement.